Apellis stock drops on Astellas drug update By Investing.com
Investing.com — Shares of Apellis Pharmaceuticals (NASDAQ:) fell 8.9% in premarket trading following news that the FDA accepted a revised…
Read MoreInvesting.com — Shares of Apellis Pharmaceuticals (NASDAQ:) fell 8.9% in premarket trading following news that the FDA accepted a revised…
Read MoreApple has said it will update an AI feature that has issued inaccurate news alerts on its latest iPhones, including…
Read MoreApple has said it will update, rather than pause, a new artificial intelligence (AI) feature that has generated inaccurate news…
Read More